Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
Cardiovascular diseases have become a major clinical burden globally. Heart failure is one of the diseases that commonly emanates from progressive uncontrolled hypertension. This gives rise to the need for a new treatment for the disease. Sacubitril/valsartan is a new drug combination that has been...
Saved in:
Main Authors: | Nor Hidayah Mustafa (Author), Juriyati Jalil (Author), Satirah Zainalabidin (Author), Mohammed S.M. Saleh (Author), Ahmad Yusof Asmadi (Author), Yusof Kamisah (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Parkia speciosa Hassk. Empty Pod Extract Alleviates Angiotensin II-Induced Cardiomyocyte Hypertrophy in H9c2 Cells by Modulating the Ang II/ROS/NO Axis and MAPK Pathway
by: Hawa Nordin Siti, et al.
Published: (2021) -
Sacubitril/valsartan in real-life clinical practice
by: Yüksel Çavuşoğlu
Published: (2021) -
Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment
by: Sarah L Anderson, et al.
Published: (2018) -
Sacubitril/Valsartan versus enalapril in nonischemic heart failure in Paradigm-Hf trial
by: Mohammed Habib
Published: (2018) -
The concentration of maternal sacubitril/valsartan transferred into human milk is negligible
by: Sirin Falconi, et al.
Published: (2024)